Rapid Dose Therapeutics Corp. DOSE
CNSX
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.50% | 28.77% | 56.65% | 17.64% | 25.06% |
| Total Depreciation and Amortization | -14.00% | -7.98% | 105.76% | 159.14% | 168.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.14% | -39.90% | -93.47% | -5.74% | -40.42% |
| Change in Net Operating Assets | 595.97% | 214.49% | 37.26% | -84.02% | -78.99% |
| Cash from Operations | 97.00% | 110.33% | 13,521.88% | 1.34% | -29.45% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 46,452.50% | -- | -- |
| Total Debt Issued | -72.01% | -86.61% | -- | -- | 1,932.11% |
| Total Debt Repaid | -26.26% | -- | -786.04% | 76.18% | 54.30% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.46% | -108.58% | -18,345.31% | 27.30% | 25.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 90.77% | -93.75% | -425.93% | 413.48% | -54.30% |